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Background: In France, decisions to limit treatment fall under the Leonetti law adopted in 2005. Leading figures
from the French world of politics, science, and justice recently claimed for amendments to the law, considering it
incomplete. This study, conducted before any legislative change, aimed to investigate the procedural aspects of
withholding/withdrawing treatment in French ICUs and their adequacy with the existing law.
Methods: The characteristics of patients qualified for a withholding/withdrawal procedure were prospectively
collected in 43 French ICUs. The study period (60 or 90 days under normal operating conditions) took place in the
first half of 2013.
Results: During the study period, 777 (14 %) of 5589 admitted patients and 584 (52 %) of 1132 patients dying in
the ICU had their treatment withheld or withdrawn. Whereas 344 patients had treatment(s) withheld (i.e., not
started or not increased if already engaged), 433 had one or more treatment(s) withdrawn. Withdrawal of treatment
was applied in 156 of 223 (70 %) brain-injured patients, compared to 277 of 554 (50 %) patients with other reasons
for admission (p < 0.01). At the time of the decision-making, the patient’s wishes were known in 181 (23 %) of the
777 cases in one or more different way(s): 73 (9.4 %) from the patient, 10 (1.3 %) by advance directives, 10 (1.3 %)
through a designated trusted person, and 108 (13.9 %) reported by the family or close relatives. An external consultant
was involved in less than half of all decisions (356 of 777, 46 %). Of the 777 patients qualified for a withholding/
withdrawal procedure, 133 (17 %) were discharged alive from the hospital (126 after withholding, 7 after withdrawal).
Conclusions: More than half of deaths in the study population occurred after a decision to withhold or withdraw
treatment. Among patients under withholding/withdrawal procedures, brain-injured subjects were more likely to
undergo a withdrawal procedure. The prevalence of advance directives and designated trusted persons was low.
Because patients’ preferences were unknown in more than three quarters of cases, decisions remained primarily
based on medical judgment. Limitations, especially withholding of treatment, did not preclude survival and
hospital discharge.
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Several decades ago, most patients who suddenly died in
the hospital underwent cardiopulmonary resuscitation
before death. From the 1950s onward, the development
of artificial life-sustaining and/or organ-substituting
techniques delivered in intensive care units (ICUs) has
shifted the definition of death from a sudden and unex-
pected event to a partially controlled process. Far from
searching to avoid death “at any cost” irrespective of the
ensuing living conditions, the primary goal of intensive
care is to return the highest number of critically ill pa-
tients to a quality of life they would find acceptable [1].
Because interfering in the dying process is not always in
the patient’s best interest, life-prolonging therapies may be
withheld or withdrawn when they are deemed “futile.”
Substantial variability exists between countries, institu-
tions, and physicians in the decision to withhold or
withdraw (WhWd) life-sustaining treatment in critically
ill patients [2–10]. At an individual level, available prog-
nostic indexes are not accurate enough to make definite
end-of-life decisions without foretelling a destiny that
would become self-fulfilling (“self-fulfilling prophecy”)
[5, 11, 12]. Moreover, withholding/withdrawal decision-
making may be considered by stakeholders (patients,
relatives, and caregivers) with different hopes and prefer-
ences influenced by age, gender, religion, culture, educa-
tion, training, and geography [5, 10, 13–20]. Legislation,
case mix, availability of ICU resources, and organization
of care in the institution/region may also influence
physicians’ attitude towards end-of-life care [4, 21].
Furthermore, the lack of a consensus-based model for
decision-making may favor variability in withholding/
withdrawal decisions, published guidelines mainly focusing
on general principles rather than practical details [22, 23].
In France, the decision to withhold or withdraw
treatment falls under the law n° 2005–370 of April 22,
2005 related to patients’ rights and to the end-of-life
(so-called Leonetti law), which authorizes the with-
holding or withdrawal of curative therapies when
deemed “useless, disproportionate or to have no other
effect than solely the artificial preservation of life” [24].
Continuing such treatment with no hope of benefit or
cure would equate to an undue therapeutic obstinacy,
especially for patients who are no longer able to ex-
press their wishes. In this setting, when current or fur-
ther life-sustaining treatments appear to be of no
overall benefit for a patient, the law stipulates that any
WhWd decision should only be made after a formal
procedure of collegial deliberation [23, 24]. Obtaining
an external opinion from an independent consultant is
a compulsory part of the procedure. In addition to
medical factors, the Leonetti law specifies that the dis-
cussion must integrate the patient’s wishes spontan-
eously expressed or written in advance directives, theopinion of the trusted person (if appointed), and the
family and/or close relatives.
Leading figures from the French world of politics, sci-
ence, and law recently claimed for amendments to the
law reinforcing patients’ rights. The aims of this pro-
spective observational study, conducted before any legis-
lative changes, were to investigate the incidence of
withholding/withdrawal decisions in French ICUs and to
evaluate how these procedures were implemented with
regard to the legislation in force.
Methods
This report is a secondary analysis of a previous study
designed to assess the theoretical eligibility as organ do-
nors of patients deceased after end-of-life decisions [25].
The study was performed in 43 French ICUs (15 units in
university-affiliated centers, 28 in general hospitals). The
institutional review board (CPP Paris Ile de France II,
IRB registration: 00001072) approved the protocol. The
study period (60 or 90 consecutive days in normal oper-
ating conditions) took place during the first half of 2013.
All patients admitted to the ICU who underwent a
WhWd procedure according to the terms of the French
Leonetti law were enrolled in the survey.
The epidemiological data recorded during the ICU
stay included age, gender, medical history, reasons for
admission, Simplified Acute Physiology Score (SAPS) II
index [26], Knaus [27], McCabe [28], and Charlson [29]
scores on admission, relevant clinical and biological
characteristics, Sequential Organ Failure Assessment
(SOFA) score [30] at the time of the WhWd decision,
reasons for the decision, implemented measures, and
outcome of the patient (deceased or discharged alive).
By convention, a SOFA organ sub-score of 3 or more
was considered as an organ failure. WhWd patients dis-
charged from the ICU were followed until discharge
from the hospital or death in the ward.
For WhWd patients, we analyzed how the limitations
were carried out with regard to the contribution of care-
givers in end-of-life decisions (including consultant physi-
cians), patient or surrogate decision-maker involvement,
and advance directives. Reasons for limiting treatment
(based on items proposed by the French intensive care so-
ciety [23]), participants in the decision-making process,
and type of treatment withheld or withdrawn were regis-
tered by the local investigator using a form developed for
this purpose.
Limitations differentially included withholding or/and
withdrawing therapies like cardiopulmonary resuscitation,
endotracheal intubation, ventilatory support, renal replace-
ment therapy, inotrope use, urgent surgery, antimicrobial
therapy, blood product transfusion, nutrition, and hydra-
tion. A three-level hierarchy for classifying decisions used
the more active mode of limitation (“stop” > “do not
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“Withdrawing” was defined as the decision to stop a treat-
ment already undertaken. “Withholding” was defined as
the decision not to start or increase a treatment beyond a
critical threshold. Patients were classified as “withheld
(Wh) patient” if withholding was the single limitation made
and as “withdrawn (Wd) patient” if treatments were both
withheld and withdrawn. Within the Wh sub-group, the
patients who had one or more “do not increase” order(s)
were compared to those exclusively qualified for “do not
start” instruction(s).
Statistical analysis
Results are expressed as mean ± standard deviation (SD)
or median and interquartile (IQR) for continuous vari-
ables and percentage with 95 % confidence interval (CI)
for categorical variables. Simple regression analysis was
used to establish the relationship between continuous
variables (SAPS II, mortality rate) and the WhWd decision
rates among the 43 participating ICUs. Comparisons of
patients were based on t test or the Mann–Whitney U test
for continuous variables and on chi-square (χ2) test or
Fisher’s exact test for categorical variables, as appropriate.
A two-tailed p value < 0.05 was considered statistically
significant. We used univariate and multivariate logistic
regression analyses with Wh/Wd as a binary procedural
variable to assess associations with categorical variables.
All relevant univariate indexes with p value less than 0.2
were included in the multivariate logistic regression model
(age > 70 years, comorbidities, reasons for admission,
organ failures). Descriptive statistics, univariate, and multi-
variate regressions were performed using Epi InfoTM
(Centers for Disease Control and Prevention, Atlanta, GA)
and the R statistical package (R Core Team, R Foundation
for Statistical Computing, Vienna, Austria).
Results
Study population
During the study period, 5589 patients (age: 62 ± 17
years; gender ratio M/F: 1.6; SAPS II: 44 ± 22) were ad-
mitted to 43 ICUs (616 beds). A total of 4457 patients
(80 %) were discharged alive from the ICU. One thousand
one hundred thirty-two patients (20 %) died in the ICU.
The median (IQR) mortality rate across the 43 participat-
ing ICUs was 20.8 (17–25) %. Over half of the deceased
patients (584/1132, 52 %) underwent a formalized WhWd
procedure before death.
Of the 5589 patients admitted, 777 (14 %; age: 68 ± 14
years; gender ratio M/F: 1.8; SAPS II: 60 ± 20; SOFA: 7
[4–11]) underwent Wh (344 patients, 6 %) and/or Wd
(433 patients, 8 %) measures (Figs. 1 and 2). Table 1 shows
the study population for each participating ICU with
regard to end-of-life decisions and outcome (deceased
or discharged alive). The median (IQR), minimum, andmaximum proportions of WhWd patients across the 43
ICUs were 13.2 (10–19), 4, and 30 %, respectively. The
proportion of WhWd patients across the 43 ICUs cor-
related with SAPS II (p < 0.02, Fig. 3a) and mortality
rates (p < 0.001, Fig. 3b). Baseline data, reasons for ad-
mission, and outcome of the 777 WhWd patients are
shown in Tables 2 (all) and 3 (separating Wh and Wd).
WhWd decision-making
Whatever the procedure (Wh or Wd), the median (IQR)
time from the ICU admission to the WhWd decision
was 4 (1–13) days. At the time of the decision-making,
the patient’s wishes were known in 181 cases (23 %), on
the basis of one or more different source(s) of informa-
tion: spontaneously voiced (73 cases, 9.4 %), written in
advance directives (10 cases, 1.3 %), expressed by a desig-
nated trusted person (10 cases, 1.3 %), and/or reported by
the family or close relatives (108 cases, 13.9 %). An external
consultant physician was involved in the decision-making
process in less than half of the 777 cases (356 patients,
46 %): 142/344 (41.3 %) and 214/433 (49.4 %) cases for Wh
and Wd, respectively (p < 0.05).
The rationales most often claimed to justify the WhWd
decision were the following:
1) No additional information needed for decision-making:
602 patients (77 %)
2) Limited subsequent functional autonomy: 581
patients (75 %)
3) Absence of curative strategy: 559 patients (72 %)
4) Non-responsive to medical therapy: 516 patients (66 %)
5) Advanced or terminal stage of a severe and
incurable disease: 474 patients (61 %)
6) Limited subsequent relational quality of life: 442
patients (57 %)
7) Limited functional autonomy before hospital
admission: 317 patients (41 %)
8) Very advanced age: 210 patients (27 %)
9) Perception of disproportionate and non-beneficial
treatment voiced by patient’s relatives: 172 patients
(22 %)
10)Wish to limit treatment voiced by patient: 110
patients (14 %)
Table 4 shows organ failures, treatment engaged, and
rationales for WhWd at the time of the decision-
making, separating Wh and Wd.
Implemented measures
The WhWd measures implemented are detailed in Fig. 4
separating “do not start,” “do not increase” (Fig. 4a), and
“stop” orders (Fig. 4b). After a first WhWd order, 89 pa-
tients (11.5 %) received additional measures for limitation
of therapy. Endotracheal ventilation was the life-sustaining
Fig. 1 Flow chart. WhWd withhold or withdraw treatment, ICU intensive care unit
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making (375 patients) and subsequently withdrawn (227),
with (147) or without (80) removal of the endotracheal
tube.
Withdrawal of treatment was applied in 156 of 223 (70 %)
brain-injured patients, compared to 277 of 554 (50 %)
patients with other reasons for admission pooled, who hadFig. 2 Characteristics of patients admitted over the study period. WhWd w
CDD circulatory determination of death, BDD brain determination of death
Score, LOS length of staytreatment equally withheld or withdrawn (p < 0.01).
WhWd patients with chronic respiratory diseases and/
or respiratory failure as reason for admission had treat-
ment preferentially withheld than withdrawn (Table 3).
For the WhWd patients classified C or D on the Knaus
scale, those with cognitive impairment (Table 3), and/or
those for whom “limited autonomy before admission” wasithhold or withdraw treatment, Alive discharged alive from the ICU,
, deceased in the ICU, M/F sex ratio, SAPS Simplified Acute Physiology

















Discharged alive from the ICU after
WhWd, N (% WhWd)
1 General 12 48 58 35 10 4 (8) 1/3 1 (25)
2 General 10 48 68 49 21 4 (8) 2/2 2 (50)
3 General 8 49 64 45 24 2 (4) 0/2 1 (50)
4 General 12 63 67 48 22 12 (19) 1/11 0 (0)
5 University 9 71 52 39 17 7 (10) 0/7 0 (0)
6 General 8 78 62 39 19 17 (22) 14/3 6 (35)
7 General 12 83 70 47 31 25 (30) 11/14 5 (20)
8 General 10 86 64 44 19 15 (17) 11/4 4 (27)
9 General 8 87 66 44 20 16 (18) 14/2 4 (25)
10 General 8 89 63 44 21 18 (20) 9/9 5 (28)
11 University 15 96 61 44 23 12 (13) 5/7 2 (17)
12 General 10 96 64 47 20 12 (13) 5/7 4 (33)
13 General 12 99 61 48 21 7 (7) 1/6 1 (14)
14 General 12 102 64 52 26 26 (25) 17/9 12 (46)
15 University 15 106 65 48 19 21 (20) 2/19 1 (5)
16 General 12 109 68 46 20 10 (9) 2/8 1 (10)
17 General 17 111 61 50 30 26 (23) 15/11 10 (38)
18 University 15 112 57 55 35 18 (16) 7/11 4 (22)
19 University 15 118 59 46 25 20 (17) 5/15 3 (15)
20 General 12 119 58 38 15 23 (19) 11/12 8 (35)
21 General 10 121 60 40 17 21 (17) 14/7 3 (14)
22 University 14 123 66 54 33 23 (19) 8/15 4 (17)
23 University 12 125 50 26 21 17 (14) 2/15 0 (0)
24 General 14 126 61 51 29 18 (14) 1/17 0 (0)
25 General 12 129 63 39 21 16 (12) 3/13 2 (13)
26 University 26 132 56 39 18 16 (12) 7/9 8 (50)
27 General 15 132 61 49 22 10 (8) 4/6 1 (10)
28 General 10 135 69 48 15 6 (4) 3/3 2 (33)
29 General 18 135 63 51 23 27 (20) 9/18 9 (33)
30 General 16 141 66 55 31 27 (19) 23/4 7 (26)
31 General 12 152 65 51 31 38 (25) 23/15 14 (37)
32 General 23 154 58 46 21 16 (10) 7/9 7 (44)
33 University 12 156 59 40 12 20 (13) 9/11 6 (30)
34 General 22 156 64 51 20 36 (23) 20/16 16 (44)
35 University 15 159 58 38 14 12 (8) 9/3 2 (17)
36 University 22 171 59 45 25 19 (11) 6/13 0 (0)
37 University 11 181 69 28 8 9 (5) 3/6 4 (44)
38 University 20 182 57 44 16 24 (13) 7/17 8 (33)
39 General 18 183 65 46 23 19 (10) 8/11 2 (11)
40 General 25 224 62 42 20 34 (15) 5/29 2 (6)
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Table 1 Study population in the 43 participating ICUs (Continued)
41 General 18 240 60 41 18 28 (12) 13/15 7 (25)
42 University 15 266 59 35 11 15 (6) 13/2 6 (40)
43 University 24 296 61 45 13 31 (10) 14/17 9 (29)
All 616 5589 777 (14) 344/433 193(25)
SAPS Simplified Acute Physiology Score, WhWd withhold or withdraw treatment, ICU intensive care unit
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likely to be withheld than withdrawn. In a multivariate ana-
lysis, neurological (OR 4.5; 95 % CI 3.3–6.2), hematological
(2.4; 1.3–4.6), renal (1.8; 1.2–2.6), and circulatory (1.5; 1.1–
2.1) failures at the time of the decision were significantly
associated with Wd vs Wh.
Among the 344 Wh patients, 105 only had “do not
start” instructions prohibiting cardiopulmonary resusci-
tation (91), renal replacement therapy (72), inotrope use
(64), endotracheal (58) or non-invasive (20) ventilation,
surgery (51), blood product transfusion (35), antibiotics
(17), and oxygenation (1). Compared to the 239 Wh pa-
tients who had “do not start” and/or “do not increase”
instructions, these 105 patients had lower median SAPS
II (49 vs 57), total SOFA score (4 vs 6), rate of respira-
tory (22 vs 40 %) and circulatory (17 vs 35 %) failures,
and death rate (33 vs 57 %) in the ICU (p < 0.01). Con-
versely, chronic respiratory diseases were more frequent
in this group (48 vs 33 %).
Patients’ outcome
Of the 4812 patients without WhWd measures, 4264 (89 %)
left the ICU alive, while 548 (11 %) died in the ICU.
Of the 777 WhWd patients, 193 (25 %) survived and
were discharged from the ICU, whereas 584 (75 %) died
in the ICU. The median (IQR) time from withholding/
withdrawal completion to death in the ICU was 2 days
(1–6) after withholding (172/344 deaths after Wh, 50 %),
























s R2 = 0.15
A
Fig. 3 Relationship between SAPS II (a), mortality rate (b), and WhWd decisio
Score, WhWd withhold or withdraw treatment, ICU intensive care unitWd, 95 %). Sixty more WhWd patients died on the ward
after discharge from the ICU, which means that 133 pa-
tients (17 % of all WhWd patients) were discharged alive
from the hospital (Fig. 1).
Discussion
Contrary to ethicists [21, 22, 31], many intensivists
clearly distinguish between withholding and withdrawal
decisions, with the former being perceived as more “pas-
sive” [3, 4, 10, 32, 33]. Physicians’ unwillingness to with-
draw life-sustaining therapy has been previously associated
with religion, culture, experience, and gender [14, 33–37].
Rather than focusing on differences between centers, our
study aimed to identify the conditions that specifically led
to withdraw and/or withhold therapy. By establishing a
three-level hierarchy of decisions (“stop” > “do not in-
crease” > “do not start”), we demonstrated that more
“active” limitations involved patients with acute organ fail-
ures, high severity indexes, and great dependence on life-
sustaining therapy. Brain-injured patients were also more
likely to undergo a withdrawal procedure, whereas patients
with chronic respiratory disease, pre-existing disability af-
fecting autonomy or cognition, and/or respiratory failure
on admission had treatment preferentially withheld than
withdrawn. Whatever the level of limitation applied, the
patient’s wishes were unknown in more than three quarters
of cases at the time of the decision-making. Thus, decisions
to limit treatment were predominantly based on medical













ICU mortality rate 
R2 = 0.29
B
n rate among the 43 participating ICUs. SAPS Simplified Acute Physiology
Table 2 Baseline data of the 777 WhWd patients
Number Percent 95 % CI
Knaus A 185 24 21.0–27.2
B 224 29 25.9–32.4
C 276 35.8 32.4–39.3
D 87 11.3 9.2–13.8
MD 5
Mc Cabe 0 315 40.9 37.4–44.4
1 299 38.8 35.3–42.3
2 157 20.4 17.6–23.4
MD 6
Risk factors
Hypertension 385 49.6 46.0–53.2
Tobacco 238 30.7 27.5–34.1
Diabetes 183 23.6 20.7–26.8
Dyslipidemia 175 22.6 19.7–25.7
Alcohol 159 20.5 17.7–23.5
Chronic diseases
Cardiac 282 36.3 32.9–39.8
Pulmonary 235 30.2 27.1–33.6
Neurological 130 16.7 14.2–19.6
Renal 109 14.0 11.7–16.7
Vascular 101 13.0 10.8–15.6
Hepatic 77 9.9 7.9–12.3
Intestinal 54 6.9 5.3–9.0
Neurological deficit
Cognition 94 12.1 9.9–14.6
Swallowing 46 5.9 4.4–7.9
Hemiplegia 22 2.8 1.8–4.3
Tetraplegia 11 1.4 0.7–2.6
Malignancies 221 28.4 25.3–31.8
Rare diseases 44 5.7 4.2–7.6
Reason for ICU admission
Respiratory failure 259 33.3 30.0–36.8
Shock and MOF 215 27.7 24.6–31.0
Post-cardiac arrest coma 150 19.3 16.6–22.3
Stroke 49 6.3 4.7–8.3
Head trauma 24 3.1 2.0–4.6
Other 80 10.3 8.3–12.7
WhWd withhold or withdraw treatment, ICU intensive care unit, MOF multiple
organ failure, CI confidence interval, MD missing data
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thoroughly argued, a consultant physician was involved at
the level of the decision-making in less than half cases.
There is an extensive literature based on questionnaire
and epidemiological surveys exploring attitudes of inten-
sive care physicians on forgoing treatments. Influencedby multiple factors, practices vary considerably between
and within countries [3, 4, 10, 32, 38–40]. Although
most Western physicians consider withholding/with-
drawing treatment usual, respondents to a recent multi-
national survey in Asia reported that they commonly
withheld (70.2 %) but rarely withdrew (20.7 %) treat-
ments [10]. In a hypothetical scenario of post-anoxic
coma with septic shock, Asian physicians are less likely
to withhold or withdraw life-sustaining treatments, and
more likely to “do everything” (53.8 %) than those in
Western countries (USA < 40 %, Southern Europe < 30 %,
Canada < 20 %, Australia < 10 %, Northern and Central
Europe < 10 %) [10, 32, 38]. In 37 ICUs from 17 European
countries (2000–2001), Sprung found that 76 % of
deaths were preceded by some kind of limitation, with a
clear downward North/South tendency between regions.
Amazingly, the French centers who volunteered to take
part in the survey could not obtain approval from their
ethics committee [3]. However, despite inter-unit vari-
ability, our data are close to those collected in 1997 by
the French LATAREA group in terms of proportion of
ICU patients undergoing WhWd measures (14 vs 11 %)
or dying after a decision to limit life-supporting therap-
ies (52 vs 53 %) and proportion of withholding/withdrawal
decisions (41/59 vs 44/56 %) [2]. These two French
surveys were completed 16 years apart, the former
(LATAREA) before and the latter (EPILAT) after enact-
ment of the Leonetti law. Considering such apparently
limited impact on WhWd rates (despite the higher me-
dian age and SAPS II in our study population), one could
argue that the law provided a legal framework for prac-
tices that already existed informally.
Because most patients in the ICU lack decision-
making capacity, WhWd discussions are often shared
between physicians, nurses, and family members or rela-
tives acting as surrogates and representing the patient’s
values and preferences [21]. One important finding from
this study is that decisions regarding WhWd are primar-
ily founded on medical judgment. The low level of
patients being directly or indirectly involved in the
decision-making (23 %) may reflect that many were un-
able to express their preferences once hospitalized, and/
or that they did not anticipate such conditions of being
before admission. While French Parliament unanimously
passed the Leonetti law in 2005 after a long and highly
publicized debate, the prevalence of advance directives
or designated trusted person remains low. The availabil-
ity and legal value of advance directives widely differ by
country and show the balance between the culture of pa-
tient autonomy and that of paternalism in medical care
[41]. In a survey of US citizens aged 60 years or older
who have died of any cause between 2000 and 2010, the
proportion of decedents with advance directives in-
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Do not start
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“Stop” orders are expressed as numbers of patients involved (of 433 Wd) 
B
Fig. 4 WhWd measures implemented separating “do not start,” “do not increase,” (a) and “stop” (b) orders. WhWd withhold or withdraw treatment,
Wd withdraw treatment
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involve an independent corroboration of the diagnosis
and prognosis by an external physician who is missing in
more than half the cases in our study. The rate of exter-
nal corroboration is only slightly higher in case of treat-
ment withdrawal (vs withholding). Whereas hospital
specialists know best in their particular domains about
the prognosis for diseases, it could be hypothesized that
only skilled intensivists could assess the benefit–risk/
burden balance of life-sustaining therapies such as venti-
latory support, inotrope use, renal replacement therapy,
or extracorporeal oxygenator. Because many hospitals
only have one ICU, referring to an independent and rele-
vant arbitration may be challenging.Treatment limitations in brain-injured patients differ
from those applied to patients with end-stage irrevers-
ible diseases. In the former category (post-anoxic coma,
stroke, head trauma), patients are rarely or never con-
scious at the time of the decision-making and cannot be
involved in the discussion. Moreover, continuation of
treatment may prolong life for months or years at the
cost of being in a severely disabled state that such pa-
tients would not have accepted [41]. In our study, brain-
injured patients qualified for a WhWd procedure, who
empirically had the poorest ability to participate directly
in decision-making, were more likely to undergo with-
drawal rather than withholding of treatment compared
to patients with non-neurologic diseases. By comparison,
Table 3 Baseline data and outcome of the 777 WhWd patients, separating withholding and withdrawal of treatment
Withholding, Withdrawal, p
N = 344 N = 433
Age (years) median (IQR) 71 (62–81) 69 (60–78) 0.03
Male 222 (64.5) 282 (65.1) 0.9
SAPS II median (IQR) 55 (44–70.5) 62 (50–75) <0.01
Knaus C and D 188 (54.7) 175 (40.4) <0.01
McCabe = 0 129 (37.5) 186 (43.0) 0.12
Charlson score 5 (3–6) 5 (3–6) 0.5
Chronic diseases:
Cardiac 135 (39.2) 147 (33.9) 0.13
Pulmonary 128 (37.2) 107 (24.7) <0.01
Neurological 63 (18.3) 67 (15.5) 0.29
Renal 50 (14.5) 59 (13.6) 0.71
Vascular 43 (12.5) 58 (13.4) 0.71
Hepatic 30 (8.7) 47 (10.9) 0.32
Intestinal 26 (7.6) 28 (6.5) 0.32
Neurological deficit:
Cognition 51 (14.5) 43 (9.9) 0.02
Swallowing 24 (7.0) 22 (5.1) 0.17
Hemiplegia 9 (2.6) 13 (3.0) 0.46
Tetraplegia 7 (2.0) 4 (0.9) 0.16
Malignancies 90 (26.2) 131 (30.3) 0.20
Rare diseases 17 (4.9) 27 (6.2) 0.27
Reasons for admission:
Respiratory failure 139 (40.4) 120 (27.7) <0.01
Shock and MOF 90 (26.2) 125 (28.9) 0.4
Brain injury 67 (19.5) 156 (36.0) <0.01
Post-cardiac arrest 48 (14.0) 102 (23.6) <0.01
Stroke 13 (3.8) 36 (8.3) <0.01
Head trauma 6 (1.7) 18 (4.2) 0.04
Other 48 (14.0) 32 (7.4) <0.01
LOS (days) in the ICU median (IQR) 9.5 (4–24) 7 (3–17.5) <0.01
Discharge alive from the ICU 172 (50.0) 21 (4.8) <0.01
Delay WhWd to the last day in the ICU median (IQR) 3 (1–9) 1 (0–3) <0.01
Values are represented as number (%), unless stated otherwise.
WhWd withhold or withdraw treatment, SAPS Simplified Acute Physiology Score, ICU intensive care unit, MOF multiple organ failure, LOS length of stay
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limited autonomy, and/or respiratory failure as reason
for admission had treatment preferentially withheld than
withdrawn in this study. One potential explanation is
that prognostic indexes based on several factors in com-
bination may predict outcome with better accuracy in
neuro-critical care than in other areas in medicine
[41, 43–46]. In case of brain injury, the predicted out-
come measure is either death or poor functional fate.
For patients with congestive cardiac failure, obstructive
bronchitis, cirrhosis, kidney disease, or cancer, it is rarelypossible to prognosticate with certainty that a chronic-
ally ill subject would not survive an acute episode [47].
These patients need to undergo a time-limited trial of
intensive care prior to any prognostication or WhWd
decision [13, 31, 48]. However, most prediction models
were not developed with the specific aim of informing
end-of-life decisions [12, 41].
Limiting treatments in critically ill patients does not
mean forgoing chances of survival. In the ETHICUS
study, the rate of patients discharged alive from the hos-
pital after withholding and withdrawal was 11 % (of
Table 4 Organ failures, treatment already engaged, and rationales
for WhWd at the time of the decision-making, separating
withholding and withdrawal of treatment
Withholding, Withdrawal, p
N = 344 N = 433
Total SOFA score median (IQR) 5 (3–9) 9 (5–13) <0.01
Total SOFA score ≥ 8 122 (35.5) 260 (60.0) <0.01
Total SOFA score ≥ 5 198 (57.6) 367 (84.8) <0.01
Total SOFA score ≥ 3 282 (82.0) 418 (96.5) <0.01
Respiratory failure 119 (34.6) 182 (42.0) 0.03
Neurologic failure 104 (30.2) 281 (64.9) <0.01
Circulatory failure 103 (29.9) 192 (44.3) <0.01
Hepatic failure 10 (2.9) 37 (8.5) <0.01
Hematologic failure 14 (4.1) 54 (12.5) <0.01
Renal failure 56 (16.3) 118 (27.3) <0.01
Treatments already engaged:
Endotracheal ventilation 213 (61.9) 375 (86.6) <0.01
Non-invasive ventilation 50 (27.9) 35 (17.3) <0.01
Inotrope use 107 (31.1) 206 (47.6) <0.01
Renal replacement therapy 24 (7.2) 100 (23.6) <0.01
Antibiotics 158 (45.9) 256 (59.1) <0.01
Blood product transfusion 46 (14.9) 77 (18.6) 0.11
Surgery needed 22 (6.4) 47 (10.9) 0.02
Rationales to justify WhWd:
No additional information needed 246 (78.1) 356 (90.8) <0.01
Limited subsequent autonomy 252 (80.3) 329 (81.4) 0.34
Absence of curative therapy 199 (61.4) 360 (86.5) <0.01
Non-responsive to treatment 180 (56.6) 336 (83.6) <0.01
End-stage incurable severe disease 185 (58.4) 289 (73.5) <0.01
Limited subsequent relational QOL 177 (57.7) 265 (68.3) <0.01
Limited autonomy before admission 184 (55.9) 133 (33.8) <0.01
Very advanced age 101 (31.9) 109 (27.9) 0.14
Excessive treatment felt by relatives 59 (18.9) 113 (28.2) <0.01
Patient’s wish to limit treatment 59 (19.1) 51 (13.1) 0.02
Awareness of patient’s preferences 86 (25.0) 95 (21.9) 0.31
External consultant physician 142 (41.3) 214 (49.4) 0.02
Values are represented as number (%), unless stated otherwise.
SOFA sequential organ failure assessment, WhWd withhold or withdraw
treatment, QOL quality of life. By convention, a SOFA organ sub-score of 3 or
more was considered as organ failure
Lesieur et al. Annals of Intensive Care  (2015) 5:15 Page 10 of 121594) and 1 % (of 1398), respectively [3]. In the French
LATAREA study, 43 % of the Wh patients and 8 % of
the Wd patients left the ICU alive [2]. A recent study
from Norway reported a survival rate on hospital dis-
charge of 37 and 0 % after withholding and withdrawal,
respectively [49]. Our own survival rates on hospital dis-
charge were 37 % after withholding and 2 % after with-
drawal. Limitations did not solely involve patients who
might die according to the physicians’ judgment. Eventhough withholding and withdrawing therapy have been
considered ethically equivalent [21, 22, 31], our survey
showed that in reality the more “active” limitations were
associated with sudden and severe pathologies and the
more “passive” with chronic diseases affecting respiration,
autonomy, or cognition. Rather than ratifying a foretold
death, the intention of the withholding decision was in
some circumstances to let nature take its course toward
death or life while avoiding non-beneficial and burdening
therapies.
The current study has several strengths. Prospectively
carried out in a large number of units throughout a single
country, it identified conditions specifically associated with
withholding or withdrawal of treatment. Limitations of
treatment were described in details separating “do not
start,” “do not increase,” and “stop” instructions. The study
also showed that the rights to dispose of one’s health con-
ferred on citizens by law (advance directives, trusted per-
son) were under-used, and as a result, that decisions
remained under physicians’ authority.
It also has limitations. First, it is uncertain whether the
units involved in the study were representative of French
practices. Second, information about sedation and anal-
gesia given during the WhWd procedure (particularly
Wd) was not collected. Third, neither the temporal steps
of the WhWd procedure (first discussion, consensus
reached within the staff, agreement obtained from fam-
ilies and/or relatives, implementation of the measures
agreed) nor the prognostic indexes used to select pa-
tients for limitations were recorded.
Conclusions
In our study involving 43 French ICUs, more than half
deaths occurred after a formal decision to withhold or
withdraw therapies deemed non-beneficial. Brain-injured
patients were more likely to undergo a withdrawal pro-
cedure, whereas patients with chronic respiratory disease
and pre-existing disability affecting autonomy or cogni-
tion had treatment preferentially withheld than with-
drawn. While the law authorizing such practices was
passed in 2005, the prevalence of advance directives and
designated trusted persons remains low. An external
consultant was involved in less than half of all decisions.
Because patients’ wishes are rarely known at the time of
the decision-making, limitations remained primarily based
on medical judgment.
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